Business / Finance

RSS

Syneron Medical's second quarter 2015 revenue up 14% to $73.5 million

Syneron Medical Ltd., a leading global aesthetic device company, today announced financial results for the three month period ended June 30, 2015.

4 Aug 2015

Capital Impact Partners provides $27.5 million in financing to support underserved communities

Capital Impact Partners announced today that it provided nearly $27.5 million in financing to projects delivering social impact for underserved communities across the U.S. during the second quarter of 2015. These projects are expected to increase access to health care services, dignified aging options, healthy food, and education for low-income people in seven states, while also creating nearly 250 jobs.

4 Aug 2015

FamilyCord announces recent acquisition of LifeLine Cryogenics

California Cryobank Stem Cell Services LLC (dba "FamilyCord"), announced the recent acquisition of LifeLine Cryogenics, an east coast cord blood and reproductive tissue bank primarily servicing the New York tristate area. LifeLine clients will maintain full access to their invaluable tissues, and all prepaid contracts will be honored.

4 Aug 2015

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Biosensors International Group, Ltd., a developer, manufacturer and marketer of innovative medical devices, today announced financial results for its first fiscal quarter ended 30 June 2015 ("Q1 FY16").

3 Aug 2015

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Array BioPharma Inc. today reported results for the fourth quarter and full year of its fiscal year ended June 30, 2015.

3 Aug 2015

Illinois Health and Science acquires IBA Molecular North America

IBA Molecular, a global leader in the manufacture and distribution of radiopharmaceuticals, announced today the completion of the previously announced sale of its US operations, IBA Molecular North America, Inc., to Illinois Health and Science (IHS), a non-profit healthcare system based in Decatur, Illinois.

3 Aug 2015

Shire acquires Foresight Biotherapeutics for $300 million

Shire plc announced today that it has acquired New York-based, privately held Foresight Biotherapeutics Inc. for $300 million.

3 Aug 2015

Encision announces financial results for Q1 fiscal year 2016

Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2016 first quarter that ended June 30, 2015.

3 Aug 2015

Soligenix signs $10M equity purchase agreement with accredited institutional investors

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has entered into a $10 million equity purchase agreement with accredited institutional investors, Kodiak Capital Group, LLC, Kingsbrook Opportunities Master Fund LP and River North Equity, LLC.

3 Aug 2015

Sorrento to develop and market monoclonal antibodies for North American, European and Japanese market

Sorrento Therapeutics, Inc. announced today that it has entered into an exclusive licensing agreement to develop and commercialize multiple prespecified and undisclosed biosimilar or biobetter antibodies from Mabtech Limited, a holding company for premier antibody development and manufacturing companies in China.

3 Aug 2015

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai Inc. announced today that its parent company Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Halozyme Therapeutics, Inc. (Headquarters: San Diego, California, President and CEO: Dr. Helen Torley) have signed a clinical collaboration agreement to evaluate Eisai's agent eribulin mesylate (brand name: Halaven, "eribulin") in combination with Halozyme's investigational drug PEGPH20 (PEGylated recombinant human hyaluronidase) in first line HER2-negative metastatic breast cancer.

31 Jul 2015

Magnaquest inks PoC with leading pharma giant for Internet of Things related initiative

Magnaquest, a leading Subscription Management, Billing and CRM solutions for video, data and cloud computing operators has signed a Proof of Concept (PoC) with a leading pharma giant for Internet of Things (IoT) related initiative.

31 Jul 2015

Essilor to acquire Brazos Private Equity Partners’ portfolio company

Brazos Private Equity Partners, LLC, a leading Dallas-based private investment firm, today announced that it has agreed to sell its portfolio company, Vision Source, to Essilor of America, Inc., a subsidiary of Paris-based Essilor International and the leading manufacturer and wholesale distributor of optical lenses in the United States.

30 Jul 2015

Zimmer Biomet announces financial results for Q2 2015

Zimmer Biomet Holdings, Inc. today reported financial results for the quarter ended June 30, 2015. The Company reported second quarter net sales of $1.17 billion, a decrease of 1.3% reported and an increase of 5.7% constant currency compared to the second quarter of 2014.

30 Jul 2015

MiMedx Group reports record revenues and earnings for Q2 2015

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the second quarter of 2015.

30 Jul 2015

HeartWare’s total revenues increase 13% to $73.6 million in second quarter 2015

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced total revenue of $73.6 million for the quarter ended June 30, 2015 compared to $70.1 million for the quarter ended June 30, 2014.

30 Jul 2015

Pantheon announces acquisition of IBSL

Pantheon Holdco Ltd., doing business as the Pantheon Healthcare Group, announced today the acquisition of Ingegneria Biomedica Santa Lucia S.p.A., a key Italian-based provider of Clinical Engineering and a large range of biomedical equipment services, from Gruppo Giglio.

30 Jul 2015

GE Healthcare to invest more than $1 billion over five years in enhanced training for healthcare professionals

In developed countries like the U.S., Europe and parts of Asia, healthcare leaders are trying to optimize efficiency, systems integration, data analytics and achieve greater productivity. In emerging economies, enabling access to affordable, basic primary care is often the most pressing concern. Healthcare systems around the world face a wide range of difficult challenges. All could benefit from training and education solutions focused specifically on their particular needs.

29 Jul 2015

PDL BioPharma signs revenue interest assignment agreement with ARIAD Pharmaceuticals

PDL BioPharma, Inc. today announced that it has entered into a revenue interest assignment agreement (the "Agreement") in which it has agreed to provide ARIAD Pharmaceuticals, Inc. with up to $200 million in revenue interest financing in exchange for royalties on the net revenues of Iclusig (ponatinib).

29 Jul 2015

Mylan receives regulatory clearance from European Commission for proposed acquisition of Perrigo

Mylan N.V. today announced that it received regulatory clearance from the European Commission under the European Union Merger Regulation (EUMR) for its proposed acquisition of Perrigo Company plc.

29 Jul 2015

Business / Finance

Syneron Medical's second quarter 2015 revenue up 14% to $73.5 million

Capital Impact Partners provides $27.5 million in financing to support underserved communities

FamilyCord announces recent acquisition of LifeLine Cryogenics

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Array Biopharma reports strong fourth quarter and full year 2015 financial results

Illinois Health and Science acquires IBA Molecular North America

Shire acquires Foresight Biotherapeutics for $300 million

Encision announces financial results for Q1 fiscal year 2016

Soligenix signs $10M equity purchase agreement with accredited institutional investors

Sorrento to develop and market monoclonal antibodies for North American, European and Japanese market

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Magnaquest inks PoC with leading pharma giant for Internet of Things related initiative

Essilor to acquire Brazos Private Equity Partners’ portfolio company

Zimmer Biomet announces financial results for Q2 2015

MiMedx Group reports record revenues and earnings for Q2 2015

HeartWare’s total revenues increase 13% to $73.6 million in second quarter 2015

Pantheon announces acquisition of IBSL

GE Healthcare to invest more than $1 billion over five years in enhanced training for healthcare professionals

PDL BioPharma signs revenue interest assignment agreement with ARIAD Pharmaceuticals

Mylan receives regulatory clearance from European Commission for proposed acquisition of Perrigo

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News